236 related articles for article (PubMed ID: 9525342)
21. Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion.
Woods KA; Camacho-Hübner C; Bergman RN; Barter D; Clark AJ; Savage MO
J Clin Endocrinol Metab; 2000 Apr; 85(4):1407-11. PubMed ID: 10770174
[TBL] [Abstract][Full Text] [Related]
22. Decreased bone mineral density in Costello syndrome.
Leoni C; Stevenson DA; Martini L; De Sanctis R; Mascolo G; Pantaleoni F; De Santis S; La Torraca I; Persichilli S; Caradonna P; Tartaglia M; Zampino G
Mol Genet Metab; 2014 Jan; 111(1):41-5. PubMed ID: 24246682
[TBL] [Abstract][Full Text] [Related]
23. Growth hormone, insulin growth factor-1, and igf binding protein-3 axis relationship with bone mineral density among healthy men.
Krassas GE; Papadopoulou P; Koliakos G; Konstantinidis T; Kalothetou K
Arch Androl; 2003; 49(3):191-9. PubMed ID: 12746097
[TBL] [Abstract][Full Text] [Related]
24. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
Colao A; Di Somma C; Pivonello R; Loche S; Aimaretti G; Cerbone G; Faggiano A; Corneli G; Ghigo E; Lombardi G
J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687
[TBL] [Abstract][Full Text] [Related]
25. Body composition and reproductive function exert unique influences on indices of bone health in exercising women.
Mallinson RJ; Williams NI; Hill BR; De Souza MJ
Bone; 2013 Sep; 56(1):91-100. PubMed ID: 23702387
[TBL] [Abstract][Full Text] [Related]
26. Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents.
Misra M; Miller KK; Stewart V; Hunter E; Kuo K; Herzog DB; Klibanski A
J Clin Endocrinol Metab; 2005 Sep; 90(9):5082-7. PubMed ID: 15998770
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men.
Johansson AG; Forslund A; Hambraeus L; Blum WF; Ljunghall S
J Bone Miner Res; 1994 Jun; 9(6):915-21. PubMed ID: 7521562
[TBL] [Abstract][Full Text] [Related]
28. [The effect of growth hormone replacement therapy on markers of bone formation and bone mineral density in elderly men].
Kozakowski J; Papierska L; Krassowski J; Zgliczyński S
Pol Arch Med Wewn; 1998 Oct; 100(4):306-12. PubMed ID: 10335039
[TBL] [Abstract][Full Text] [Related]
29. Bone mineral density in patients with growth hormone deficiency: does a gender difference exist?
Hitz MF; Jensen JE; Eskildsen PC
Clin Endocrinol (Oxf); 2006 Dec; 65(6):783-91. PubMed ID: 17121531
[TBL] [Abstract][Full Text] [Related]
30. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
[TBL] [Abstract][Full Text] [Related]
31. Growth hormone treatment of osteoporotic postmenopausal women - a one-year placebo-controlled study.
Sääf M; Hilding A; Thorën M; Troell S; Hall K
Eur J Endocrinol; 1999 May; 140(5):390-9. PubMed ID: 10229902
[TBL] [Abstract][Full Text] [Related]
32. Relationship among insulinlike growth factor I concentrations, bone mineral density, and biochemical markers of bone turnover in postmenopausal women: a population-based study.
Nabipour I; Larijani B; Beigi S; Jafari SM; Amiri M; Assadi M; Pazoki R; Amiri Z; Sanjdideh Z
Menopause; 2008; 15(5):934-9. PubMed ID: 18451743
[TBL] [Abstract][Full Text] [Related]
33. The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3.
Gargosky SE; Wilson KF; Fielder PJ; Vaccarello MA; Guevara-Aguirre J; Diamond FB; Baxter RC; Rosenbloom AL; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Dec; 77(6):1683-9. PubMed ID: 7505289
[TBL] [Abstract][Full Text] [Related]
34. Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines.
Street ME; Spaggiari C; Ziveri MA; Volta C; Federico G; Baroncelli GI; Bernasconi S; Saggese G
Horm Res; 2006; 66(4):162-8. PubMed ID: 16804317
[TBL] [Abstract][Full Text] [Related]
35. Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: a 1-year prospective study.
Arikoski P; Komulainen J; Riikonen P; Voutilainen R; Knip M; Kröger H
J Clin Endocrinol Metab; 1999 Sep; 84(9):3174-81. PubMed ID: 10487683
[TBL] [Abstract][Full Text] [Related]
36. Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome.
Vaccarello MA; Diamond FB; Guevara-Aguirre J; Rosenbloom AL; Fielder PJ; Gargosky S; Cohen P; Wilson K; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Jul; 77(1):273-80. PubMed ID: 7686916
[TBL] [Abstract][Full Text] [Related]
37. Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa.
Misra M; Miller KK; Cord J; Prabhakaran R; Herzog DB; Goldstein M; Katzman DK; Klibanski A
J Clin Endocrinol Metab; 2007 Jun; 92(6):2046-52. PubMed ID: 17356044
[TBL] [Abstract][Full Text] [Related]
38. Impact of growth hormone status on body composition and the skeleton.
Mukherjee A; Murray RD; Shalet SM
Horm Res; 2004; 62 Suppl 3():35-41. PubMed ID: 15539797
[TBL] [Abstract][Full Text] [Related]
39. Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients.
Scillitani A; Chiodini I; Carnevale V; Giannatempo GM; Frusciante V; Villella M; Pileri M; Guglielmi G; Di Giorgio A; Modoni S; Fusilli S; Di Cerbo A; Liuzzi A
J Bone Miner Res; 1997 Oct; 12(10):1729-36. PubMed ID: 9333135
[TBL] [Abstract][Full Text] [Related]
40. The Impact of congenital, severe, untreated growth hormone (GH) deficiency on bone size and density in young adults: insights from genetic GH-releasing hormone receptor deficiency.
Maheshwari HG; Bouillon R; Nijs J; Oganov VS; Bakulin AV; Baumann G
J Clin Endocrinol Metab; 2003 Jun; 88(6):2614-8. PubMed ID: 12788864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
